Disclosure

EFPIA Disclosure

Nigaard is the Nordics based wholly owned subsidiary of Zambon S.p.A. headquartered in Italy. Zambon S.p.A. is an Italian pharmaceutical company. Zambon has been involved in the «Disclosure» project since 2015 with the aim of implementing the EFPIA Disclosure Code on Transfers of Value.
Specifically, the Disclosure Code requires that transfers of value between the pharmaceutical industry, healthcare professionals and healthcare organisations be published on a yearly basis, with reporting starting in 2016.
Nigaard Pharma AS was acquired by Zambon in July 2015. From the date of acquisition until December 2015 Nigaard did not carry out any activities relevant for EFPIA Disclosure as it was fully involved in the integration process in Zambon. For that reason publication of transfer of values of Nigaard will be effective starting from June 2017.

What are transfers of value?

Transfers of value are pecuniary benefits granted, such as:

  • Hospitality provided to a Healthcare Professional (HCP) for participating in a conference;
  • Compensation to Healthcare Professionals (HCP) and Healthcare Organisations (HCO) for a professional engagement based on the type of activity required;
  • Sponsorship of continuous medical education events

How can the full autonomy of Healthcare Professionals be ensured?

It is essential to maintain a continuous dialogue and discussion between pharmaceutical companies and Healthcare Professionals for the development of medicines and our collective wellbeing.

These relationships must be managed in a manner that the physicians can maintain their prescribing autonomy.
Disclosure of financial payments made to Healthcare Professionals and organisations will avoid any misunderstandings about physician autonomy.

Respect for privacy

Because the reporting of the transfer of value amounts received by individual Healthcare Professionals and Healthcare Organisations involves the publication of their personal information, Nigaard has left the decision entirely to the Healthcare Professional and Healthcare Organisation whether to authorise or deny the publication of transfers of value made to them.

Publication of values

This site contains a table that indicates the first and last name and address of the Healthcare Professional and the exact amount of the pecuniary benefits received only if the Healthcare Professional has authorised publication. The table also reports amounts of the pecuniary benefits to Healthcare Organisations only if the Healthcare Organisation has authorised publication.

If a Healthcare Professional or Healthcare Organisation denies publication, the transfer of value amounts made to them will be included in the aggregate value, in other words in the total amount of values paid by Nigaard.

Indirect transfers

It should be noted that not all transfers of value published on a named basis – upon authorisation of the Healthcare Professional – have been materially collected by the Healthcare Professional. The company has very often paid the corresponding amount indirectly and not to the Healthcare Professional, for example to an agency to cover the travel costs for the Healthcare Professional to attend an educational meeting deemed useful for their profession.

Nigaard extends their thanks

Nigaard extends its thanks to those Healthcare Professionals and Healthcare Organisations having authorised the publication of transfers of value on a named basis that occurred since 2016.

 

Finland

Disclosure TEMPLATE
Article 2 - Section 2.03
Full Name HCPs: City of Principal Practice HCOs: city where registered Country of Principal Practice Principal Practice Address Unique country local identifyer OPTIONAL Donations and Grants to HCOs (Art. 3.01.1.a) Contribution to costs of Events (Art. 3.01.1.b & 3.01.2.a) Fee for service and consultancy (Art. 3.01.1.c & 3.01.2.c)        TOTAL OPTIONAL
(Art. 1.01) (Art. 3) (Schedule 1) (Art. 3) (Art. 3) Sponsorship agreements with HCOs / third parties appointed by HCOs to manage an Event Registration Fees Travel & Accomodation Fees Related expenses agreed in the fee for service or consultancy contract
  HCPs INDIVIDUAL NAMED DISCLOSURE - one line per HCP (i.e. all transfers of value during a year for an individual HCP will be summed up: itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate)
Matti Nikkanen Kuusankoski Finland Pohjois-Kymen sairaala FI 912 615 1.527
Harri Hirvonen Turku Finland Lääkäriasema Mehiläinen, Turku FI 912 615 1.527
Anu Toikka Hämeenlinna Finland Kanta-Hämeen Keskussairaala FI 1.495 1.093 2.588
Juha-Pekka Kervinen Tampere Finland Tampereen Yliopistollinen sairaala FI 1.495 1.093 2.588
Valtteri Kaasinen Turku Finland Turun Yliopistollien Keskussairaala FI 490 416 906
Anne-Maria Kuopio Jyväskylä Finland Mehiläinen FI 490 416 906
Tapani Keränen Tampere Finland Käpytie 12 FI 2.000 2.000
Jaana Korpela Turku Finland Turun Yliopistollien Keskussairaala FI 989 989
Elina Rauhala Turku Finland Terveystalo Pulssi, Turku FI 1.029 1.029
Rebekka Ortiz Tampere Finland Tampereen Yliopistollinen sairaala FI 1.272 1.272
Lauri Herrala Seinäjoki Finland Seinäjoen keskussairaala FI 1.042 1.042
OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons
Aggregate amount attributable to transfers of value to such Recipients - Art. 3.2 859 832 1.691
Number of Recipients (named list, where appropriate) - Art. 3.2 2 2 4
% of total transfers of value to individual HCPs - Art. 3.2 25% 17% N/A
HCOs INDIVIDUAL NAMED DISCLOSURE - one line per HCO (i.e. all transfers of value during a year for an individual HCO will be summed up: itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate)
Suomen Neurologinen Yhdistys Turku Finland PL 52, 20521 Turku Finland 13.500 13.500
OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons
Aggregate amount attributable to transfers of value to such Recipients - Art. 3.2 0
Number of Recipients (named list, where appropriate) - Art. 3.2 0
% of total transfers of value to individual HCOs - Art. 3.2 N/A
R&D AGGREGATE DISCLOSURE
Transfers of Value for Research & Development as defined - Article 3.04 and Schedule 1 CE 0 0

Norway

Disclosure TEMPLATE
Article 2 - Section 2.03
Full Name HCPs: City of Principal Practice HCOs: city where registered Country of Principal Practice Principal Practice Address Unique country local identifyer OPTIONAL Donations and Grants to HCOs (Art. 3.01.1.a) Contribution to costs of Events (Art. 3.01.1.b & 3.01.2.a) Fee for service and consultancy (Art. 3.01.1.c & 3.01.2.c)        TOTAL OPTIONAL
(Art. 1.01) (Art. 3) (Schedule 1) (Art. 3) (Art. 3) Sponsorship agreements with HCOs / third parties appointed by HCOs to manage an Event Registration Fees Travel & Accomodation Fees Related expenses agreed in the fee for service or consultancy contract
  HCPs INDIVIDUAL NAMED DISCLOSURE - one line per HCP (i.e. all transfers of value during a year for an individual HCP will be summed up: itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate)
Dr Espen Dietrichs Hvalstad Norway Solstad terasse 43 NO 5.000 5.000
Dr Kari Anna Björnarå Vestre Viken Norway 3014 Drammen NO 5.000 5.000
Dr Vidar Gundersen Oslo Norway Rikshospitalet, 0424 Oslo NO 5.000 5.000
OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons
Aggregate amount attributable to transfers of value to such Recipients - Art. 3.2 0
Number of Recipients (named list, where appropriate) - Art. 3.2 0
% of total transfers of value to individual HCPs - Art. 3.2 N/A
HCOs INDIVIDUAL NAMED DISCLOSURE - one line per HCO (i.e. all transfers of value during a year for an individual HCO will be summed up: itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate)
Normodis Oslo Norway Ombersveien 0 33.500 33.500
OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons
Aggregate amount attributable to transfers of value to such Recipients - Art. 3.2 0
Number of Recipients (named list, where appropriate) - Art. 3.2 0
% of total transfers of value to individual HCOs - Art. 3.2 N/A
R&D AGGREGATE DISCLOSURE
Transfers of Value for Research & Development as defined - Article 3.04 and Schedule 1 CE 0 0

Sweden

Disclosure TEMPLATE
Article 2 - Section 2.03
Full Name HCPs: City of Principal Practice HCOs: city where registered Country of Principal Practice Principal Practice Address Unique country local identifyer OPTIONAL Donations and Grants to HCOs (Art. 3.01.1.a) Contribution to costs of Events (Art. 3.01.1.b & 3.01.2.a) Fee for service and consultancy (Art. 3.01.1.c & 3.01.2.c)        TOTAL OPTIONAL
(Art. 1.01) (Art. 3) (Schedule 1) (Art. 3) (Art. 3) Sponsorship agreements with HCOs / third parties appointed by HCOs to manage an Event Registration Fees Travel & Accomodation Fees Related expenses agreed in the fee for service or consultancy contract
  HCPs INDIVIDUAL NAMED DISCLOSURE - one line per HCP (i.e. all transfers of value during a year for an individual HCP will be summed up: itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate)
Peter Berglund Gothenburg Sweden Sahlgrenska univ. Hospital SE 8.000 8.000
Johan Lökk Stockholm Sweden Karolinska univ. Hospital SE 8.000 8.000
Per Odin Lund Sweden SUS, 221 85 Lund SE 10.000 10.000
Örjan Skogar Jönköping Sweden Tulpanstigen 36 Jönköping SE 8.000 8.000
OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons
Aggregate amount attributable to transfers of value to such Recipients - Art. 3.2
Number of Recipients (named list, where appropriate) - Art. 3.2
% of total transfers of value to individual HCPs - Art. 3.2 N/A
HCOs INDIVIDUAL NAMED DISCLOSURE - one line per HCO (i.e. all transfers of value during a year for an individual HCO will be summed up: itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate)
Patientkraft, Svenska Parkinsonförb Stockholm Sweden Skeppargatan 52 SE 105.850 105.850
Svenska Neurologfören Stockholm Sweden Karolinska sjukhuset SE 60.000 60.000
Svenska Parkinsonakademin Lund Sweden SUS, Lund SE 18.000 18.000
Barn och ungdomsmedicinska kliniken Jönköping Sweden Länssjukhuset Ryhov SE 5.000 5.000
Stockholm CF-center Stockholm Sweden Karolinska sjukhuset SE 4.500 4.500
SWEMODIS Stockholm Sweden Karolinska sjukhuset SE 41.637 41.637
Scandmodis Stockholm Sweden SUS, Lund SE 100.000 100.000
Neurologföreningen Stockholm Sweden Karolinska sjukhuset SE 75.000 75.000
OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons
Aggregate amount attributable to transfers of value to such Recipients - Art. 3.2 0
Number of Recipients (named list, where appropriate) - Art. 3.2 0
% of total transfers of value to individual HCOs - Art. 3.2 N/A
R&D AGGREGATE DISCLOSURE
Transfers of Value for Research & Development as defined - Article 3.04 and Schedule 1 CE 0 0